What Is The Current and Historic Market Size Analysis Of The Microbial Identification Methods Market?
The microbial identification methods market has seen considerable growth due to a variety of factors.
• The microbial identification methods market has seen significant growth in recent years. It is expected to increase from $5.09 billion in 2024 to $5.5 billion in 2025, at a CAGR of 8.0%.
This growth can be attributed to the rising prevalence of infectious diseases, increased funding for research and development in diagnostics, greater focus on infection control measures in healthcare, heightened food safety concerns, and the growing demand for microbial identification methods.
What Are The Predictions for The Microbial Identification Methods Market in the Coming Years?
The microbial identification methods market is expected to maintain its strong growth trajectory in upcoming years.
• The microbial identification methods market is anticipated to expand significantly, reaching $7.4 billion by 2029 at a CAGR of 7.7%.
The market's growth can be attributed to a rising demand for rapid microbiology testing, progress in microbial research, greater adoption of automated systems, higher disposable incomes, and government food safety initiatives. Notable trends include new product introductions, innovations in identification techniques, the adoption of automated bacterial identification systems, and progress in microfluidics, robotics, and nanotechnology.
Which Drivers Are Accelerating Growth In The Microbial Identification Methods Market?
The increasing prevalence of infectious diseases is expected to accelerate the growth of the microbial identification methods market. Infectious diseases are caused by pathogens such as bacteria, viruses, fungi, and parasites. Conditions like HIV/AIDS, tuberculosis, and malaria are among the most significant infectious diseases. The rise in infectious diseases is linked to antimicrobial resistance, climate change, and growing populations. Microbial identification methods are crucial for diagnosing, treating, and preventing these diseases. For instance, the Government of Canada reported a rise in rabies samples submitted, with 135 in October 2022 and 159 in November 2022. Additionally, the CDC reported a 5.9% increase in tuberculosis cases in the U.S. in 2022 compared to 2021, further driving the market.
What Are The Core Segments Of The Global Microbial Identification Methods Market?
The microbial identification methods market covered in this report is segmented –
1) By Method: Genotypic, Phenotypic, Proteotypic
2) By Type: Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, Other Type
3) By End User: Pharmaceutical And Biotechnology Companies, Hospitals And Diagnostic Laboratories, Food Testing Laboratories, Other End-Users
Subsegments:
1) By Genotypic: Polymerase Chain Reaction (PCR), 16S rRNA Sequencing, DNA Microarrays, Next-Generation Sequencing (NGS), Whole Genome Sequencing (WGS), Ribotyping, Fluorescence In Situ Hybridization (FISH), Random Amplified Polymorphic DNA (RAPD) Analysis
2) By Phenotypic: Culture-Based Methods, Biochemical Testing, Microscopic Examination, Gram Staining, Antibiotic Susceptibility Testing (AST), Growth Pattern Identification, Colony Morphology Characterization
3) By Proteotypic: Mass Spectrometry (MALDI-TOF MS), Western Blotting, Protein Profiling, Immunoassays (ELISA), Two-Dimensional Gel Electrophoresis
Pre-Book The Microbial Identification Methods Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Microbial Identification Methods Market?
Major companies in the microbial identification methods market strive to fortify their market position by developing innovative solutions such as in vitro diagnostic (IVD) solutions for mycobacteria and fungi. These solutions encompass a variety of products and technologies designed to detect and identify mycobacterial and fungal pathogens in clinical specimens. For instance, Bruker Corporation, a US-based manufacturer of scientific instruments, rolled out its new mycobacteria and fungi IVD solution, MALDI Biotyper IVD software, in April 2023. This platform uses MALDI-TOF (matrix-assisted laser desorption/ionization-time of flight) mass spectrometry technology to provide a quick and accurate identification of these pathogens from cultured samples, dramatically cutting down the time compared to conventional methods. These revolutionary solutions also come with wider databases and reliable software algorithms that improve specificity and sensitivity, enabling the accurate identification of a wider spectrum of mycobacterial and fungal species.
Who Are the Key Players In The Microbial Identification Methods Market?
Major companies operating in the microbial identification methods market are:
• Merck KGaA
• Sumitomo Corporation
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Becton Dickinson and Company
• GE Healthcare
• Avantor Inc.
• Eurofins Scientific SE
• Lonza Group AG
• Sartorius AG
• Charles River Laboratories International Inc.
• bioMerieux SA
• Shimadzu Corporation
• Waters Corporation
• Bio-Rad Laboratories Inc.
• Bruker Corporation
• Qiagen N.V.
• Beckman Coulter Inc.
• HiMedia Laboratories.
• Hardy Diagnostics.
• LuminUltra Technologies Ltd.
• Biolog Inc.
What Are The Regional Insights Into The Microbial Identification Methods Market?
North America was the largest region in the microbial identification methods market in 2023. The regions covered in the microbial identification methods market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
